Lipigon Pharmaceuticals AB (LPGO) — Cash Flow Quality Index

Latest as of June 2023: -1.46x

Lipigon Pharmaceuticals AB (LPGO) has a Cash Flow Quality Index of -1.46x as of June 2023. Operating cash flow of Skr-10.38 Million is below net income of Skr7.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore LPGO asset base for the complete picture of this company's asset base.

Cash Flow Quality Index

-1.46x

Operating CF / Net Income

Operating Cash Flow

Skr-10.38 Million

SEK

Net Income

Skr7.13 Million

SEK

Data as of

Jun 2023

Most recent filing

Annual Cash Flow Quality Index for Lipigon Pharmaceuticals AB (None–None)

Year-by-year earnings quality comparison for Lipigon Pharmaceuticals AB. For live market cap and the full company financial profile, see LPGO market cap overview.

Year	Quality Index	Operating CF (SEK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.